View Cart (0 items)

Pharmaceutical

Hikma Pharmaceuticals to take over US generic injectables manufacturer

London-based multinational company Hikma Pharmaceuticals PLC has reached an asset acquisition agreement with Ben Venue Laboratories for the purchase of its U.S. generic injectables division, Bedford Laboratories, for $300 million.
Read More

US pharma major Abbott to pay $2.9 billion for Chile's CFR

U.S. pharmaceuticals and healthcare products major Abbott Laboratories has agreed to acquire Chile-based pharmaceutical firm CFR Pharmaceuticals SA in a deal worth $2.9 billion.
Read More

Sun Pharma's response to FDA import ban seen as 'inadequate'

According to the U.S. Food and Drug Administration, Sun Pharma has failed to take sufficient measures to correct the violations that led to the enforcement action.
Read More

Teva recalls 39,000 bottles of drug products due to manufacturing standards violations

The recalled production includes 2,532 bottles of anti-diabetes drug glyburide, which are being pulled off the U.S. market due to deviations from Current Good Manufacturing Practice.
Read More

EU, US health officials team up to fight antimicrobial resistance

Health officials from both sides of the Atlantic have been working together to tackle antimicrobial resistance under their joint Transatlantic Taskforce on Antimicrobial Resistance.
Read More

Bayer to take over Merck's consumer care business in $14.2 billion deal

German pharmaceutical giant Bayer is acquiring the over-the-counter medicines business of U.S. rival Merck & Co., Inc.
Read More

Sanofi looking to shed multi-billion portfolio to optimize assets

French pharmaceutical giant Sanofi SA is exploring options to sell a range of older drugs, with an estimated value of the portfolio between $7 billion and $8 billion.
Read More

US wholesale sector consolidation hits Indian drug makers

The U.S. pharmaceutical sector is going through a period of consolidation and this has already has a noticeable effect on Indian drug makers.
Read More

Pfizer proposes $101 billion takeover to AstraZeneca, reports claim

U.S. pharmaceutical company Pfizer has expressed interest in taking over Anglo-Swedish giant AstraZeneca for a total of $101 billion.
Read More

Lupin recalls 9,000 bottles of antibiotic drug

Two lots of Suprax, an antibiotic drug used to treat bacterial infections, are being withdrawn from the U.S. market because the product does not meet federal standards for impurities.
Read More